Literature DB >> 6122462

Lack of effect of ranitidine on warfarin action.

M J Serlin, R G Sibeon, A M Breckenridge.   

Abstract

1 In five volunteers taking daily subtherapeutic doses of warfarin the addition of ranitidine 200 mg twice daily for 14 days did not affect prothrombin time or plasma warfarin concentration. 2 Ranitidine had no effect on the single dose pharmacodynamics and pharmacokinetics of warfarin in the rat. 3 Ranitidine had no effect on pentobarbitone sleeping time in the rat whereas cimetidine significantly prolonged the sleeping time. 4 The interaction between cimetidine and oral anticoagulants is unrelated to histamine H2-receptor antagonism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6122462      PMCID: PMC1401939          DOI: 10.1111/j.1365-2125.1981.tb01308.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  A study of the effect of anticoagulants on [3H]vitamin K1 metabolism and prothrombin complex activity in the rabbit.

Authors:  B K Park; J B Leck; A C Wilson; M J Serlin; A M Breckenridge
Journal:  Biochem Pharmacol       Date:  1979-04-15       Impact factor: 5.858

2.  GLC determination of warfarin in human plasma.

Authors:  D G Kaiser; R S Martin
Journal:  J Pharm Sci       Date:  1974-10       Impact factor: 3.534

3.  Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.

Authors:  A Yacobi; L B Wingard; G Levy
Journal:  J Pharm Sci       Date:  1974-06       Impact factor: 3.534

4.  Delayed clearance of diazepam due to cimetidine.

Authors:  U Klotz; I Reimann
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

5.  Cimetidine potentiates the anticoagulant effect of warfarin by inhibition of drug metabolism.

Authors:  M J Serlin; M Challiner; B K Park; P A Turcan; A M Breckenridge
Journal:  Biochem Pharmacol       Date:  1980-07-01       Impact factor: 5.858

6.  Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.

Authors:  N R Peden; J H Saunders; K G Wormsley
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

7.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

8.  Effect of cimetidine on microsomal drug metabolism in man.

Authors:  J Puurunen; E Sotaniemi; O Pelkonen
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

9.  Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.

Authors:  D A Henry; I A Macdonald; G Kitchingman; G D Bell; M J Langman
Journal:  Br Med J       Date:  1980-09-20
  9 in total
  19 in total

Review 1.  Clinical relevance of cimetidine drug interactions.

Authors:  A F Shinn
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

2.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

Review 3.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

Review 4.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

5.  Lack of inhibitory effect of metronidazole on theophylline disposition in healthy subjects.

Authors:  G I Adebayo; A F Mabadeje
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

Review 6.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

7.  Failure of ranitidine to interact with propranolol.

Authors:  A M Heagerty; C M Castleden; L Patel
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01

Review 8.  Drug interactions with warfarin.

Authors:  M J Serlin; A M Breckenridge
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

Review 9.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 10.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.